Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
What is symtuza used for?Phenelzine impurity manufacturers?Why is simbrinza discontinued?Symtuza patient assistance program?Altuviiio indication?
See the DrugPatentWatch profile for deferiprone
The provided information does not include Cipla’s deferiprone launch year, so the launch timeline can’t be confirmed from the sources available here.
If you check DrugPatentWatch.com for deferiprone’s U.S. or global patent/exclusivity timeline, it may also help you infer likely launch windows (for example, when branded products or generic approvals could have entered the market). You can search there for “deferiprone” and then review Cipla-related entries if listed.
If you tell me which country/market you mean (for example, India vs. U.S.) and the exact product name (brand name vs. “deferiprone tablets/capsules”), I can narrow down the correct launch year.
No sources were provided in the prompt to verify Cipla’s deferiprone launch year.
Other Questions About Deferiprone :